Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for Male Partners of Women with Recurrent BV
NCT02209519Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole in bacterial vaginosis (BV), sponsored by University of Alabama at Birmingham. Started Feb 2015; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02209519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209519.